Improved microarray-based decision support with graph encoded interactome data

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Daemen, Anneleen ^a   Signoretto, Marco ^a   Gevaert, Olivier ^a   Suykens, Johan A K ^a   de Moor, Bart ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ARTICLE; CANCER CLASSIFICATION; CLASSIFIER; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; GENE TARGETING; INFORMATION PROCESSING; KERNEL METHOD; METABOLOMICS; MICROARRAY ANALYSIS; PROGNOSIS; PROTEIN PROTEIN INTERACTION; SUPPORT VECTOR MACHINE; ARTIFICIAL NEURAL NETWORK; DNA MICROARRAY; GENETICS; HUMAN; METABOLISM; NEOPLASM; PROTEIN BINDING;

HUMANS; METABOLIC NETWORKS AND PATHWAYS; MICRORNAS; NEOPLASMS; NEURAL NETWORKS (COMPUTER); OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN BINDING;

EID: 77956318400     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010225     Document Type: Article

References (77)

1. Alon A, Barkai N, Notterman DA, GishK, Ybarra S, et al. (1999) Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci U S A 96: 6745-6750.
2. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, et al. (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286: 531-537.
3. Singh D, Febbo PG, Ross K, Jackson DG, Manola J, et al. (2002) Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 1: 203-209.
4. Huang E, Cheng SH, Dressman H, Pittman J, Tsou MH, et al. (2003) Gene expression predictors of breast cancer outcomes. Lancet 361: 1590-1596.
5. Berchuck A, Iversen ES, Lancaster JM, Pittman J, Luo J, et al. (2005) Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Clin Cancer Res 11: 3686-3696.
6. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, et al. (2006) Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10: 529-541.
7. Oakman C, Bessi S, Zafarana E, Galardi F, Biganzoli L, et al. (2009) New diagnostics and biological predictors of outcome in early breast cancer. Breast Cancer Res 11: 205.
8. Yu JX, Sieuwerts AM, Zhang Y, Martens JWM, Smid M, et al. (2007) Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer. BMC Cancer 7: 182.
9. Desmedt C, Sotiriou C (2006) Proliferation: the most prominent predictor of clinical outcome in breast cancer. Cell Cycle 5: 2198-2202.
10. Haupt S, Berger M, Goldberg Z, Haupt Y (2003) Apoptosis - the p53 network. J Cell Sci 116: 4077-4085.
11. Daemen A, Gevaert O, Ojeda F, Debuquoy A, Suykens JAK, et al. (2009) A kernel-based integration of genome-wide data for clinical decision support. Genome Med 1: 39.
12. Simon R, Radmacher MK, Dobbin K, McShane LM (2003) Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst 95: 14-18.
13. Ein-Dor L, Kela I, Getz G, Givol D, Domany E (2005) Outcome signature genes in breast cancer: is there a unique set? Bioinformatics 21: 171- 178.
14. Vert J-P, Kanehisa M (2003) Extracting active pathways from gene expression data. Bioinformatics 19: ii238-ii244.
15. Hanisch D, Zien A, Zimmer R, Lengauer T (2002) Co-clustering of biological networks and gene expression data. Bioinformatics 18: S145-S154.
16. Li C, Li H (2008) Network-constrained regularization and variable selection for analysis of genomic data. Bioinformatics 24: 1175-1182.
17. Galperin MY, Cochrane GR (2009) Nucleic Acids Research annual database issue and the NAR online molecular biology database collection in 2009. Nucleic Acids Res 37: D1-D4.
18. Chuang H-Y, Lee E, Liu Y-T, Lee D, Ideker T (2007) Network-based classification of breast cancer metastasis. Mol Syst Biol 3: 140.
19. Lee E, Chuang HY, Kim JW, Ideker T, Lee D (2008) Inferring pathway activity toward precise disease classification. PLoS Comput Biol 4: e1000217.
20. Mani KM, Lefebvre C, Wang K, Lim WK, Basso K, et al. (2008) A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas. Mol Syst Biol 4: 169.
21. Taylor IW, Linding R, Warde-Farley D, Liu Y, Pesquita C, et al. (2009) Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nature Biotech 27: 199-204.
22. Rapaport F, Zinovyev A, Dutreix M, Barillot E, Vert J-P (2007) Classification of microarray data using gene networks. BMC Bioinformatics 8: 35.
23. Kanehisa M, Goto S, Furumichi M, Tanaba M, Hirakawa M (2010) KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 38: D355-D360.
24. Matthews L, Gopinath G, Gillespie M, Caudy M, Croft D, et al. (2009) Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res 37: D619-D622.
25. Brown KR, Jurisca I (2007) Unequal evolutionary conservation of human protein interactions in interologous networks. Genome Biol 8: R95.
26. Shawe-Taylor J, Cristianini N (2004) Kernel methods for pattern analysis. Cambridge: Cambridge University Press. 488 p.
27. Suykens JAK, Vandewalle J (1999) Least squares support vector machine classifiers. Neural Processing Lett 9: 293-300.
28. Suykens JAK, Van Gestel T, De Brabanter J, De Moor B, Vandewalle J (2002) Least Squares Support Vector Machines. Singapore: World Scientific. 318 p.
29. Cawley GC (2006) Leave-one-out cross-validation based model selection criteria for weighted LS-SVMs. Proc Int Joint Conf in Neural Networks. pp 1661-1668.
30. Fouss F, Pirotte A, Renders J-M, Saerens M (2007) Random-walk computation of similarities between nodes of a graph with application to collaborative recommendation. IEEE Transactions on Knowledge and Data Engineering 19: 355-369.
31. Lewis DP, Jebara T, Noble WS (2006) Support vector machine learning from heterogeneous data: an empirical analysis using protein sequence and structure. Bioinformatics 22: 2753-2760.
32. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
33. Bild AH, Yao G, Chang JT, Wang Q, Potti A, et al. (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439: 353-357.
34. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, et al. (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. New Engl J Med 346: 1937-1947.
35. Wang Y, Klijn JGM, Zhang Y, Sieuwerts AM, Look MP, et al. (2005) Geneexpression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671-679.
36. Dai M, Wang P, Boyd AD, Kostov G, Athey B, et al. (2005) Evolving gene/ transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 33: e175.
37. Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, et al. (2001) Missing value estimation methods for DNA microarrays. Bioinformatics 17: 520-525.
38. Ma H, Sorokin A, Mazein A, Selkov A, Selkov E, et al. (2007) The Edinburgh human metabolic network reconstruction and its functional analysis. Mol Syst Biol 3: 135.
39. Caspi R, Altman T, Dale JM, Dreher K, Fulcher CA, et al. (2010) The MetaCyc Database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases. Nucleic Acids Res 38: D473-D479.
40. Romero P, Wagg J, Green ML, Kaiser D, Krummenacker M, et al. (2004) Computational prediction of human metabolic pathways from the complete human genome. Genome Biol 6: R2.
41. Prieto C, De Las Rivas J (2006) APID: Agile Protein Interaction DataAnalyzer. Nucleic Acids Res 34: W298-W302.
42. Breitkreutz B-J, Stark C, Reguly T, Boucher L, Breitkreutz A, et al. (2008) The BioGRID Interaction Database: 2008 update. Nucleic Acids Res 36: D637-D640.
43. Bader G, Betel D, Hogue C (2003) BIND: the Biomolecular Interaction Network Database. Nucleic Acids Res 31: 248-250.
44. Ceol A, Chatr-Aryamontri A, Licata L, Peluso D, Briganti L, et al. (2010) MINT, the Molecular INTeraction database: 2009 update. Nucleic Acids Res 38: D532-D539.
45. Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, et al. (2009) Human Protein Reference Database - 2009 update. Nucleic Acids Res 37: D767-D772.
46. Aranda B, Achuthan P, Alam-Faruque Y, Armean I, Bridge A, et al. (2010) The IntAct molecular interaction database in 2010. Nucleic Acids Res 38: D525-D531.
47. Salwinski L, Miller CS, Smith AJ, Pettit FK, Bowie JU, et al. (2004) The database of interacting proteins: 2004 update. Nucleic Acids Res 32: D449-D451.
48. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, et al. (2009) STRING 8 - a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 37: D412-D416.
49. Raghavachari B, Tasneem A, Przytycka TM, Jothi R (2008) DOMINE: a database of protein domain interactions. Nucleic Acids Res 36: D656-D661.
50. Björkholm P, Sonnhammer ELL (2009) Comparative analysis and unification of domain-domain interaction networks. Bioinformatics 25: 3020-3025.
51. Sigrist CJ, Cerutti L, de Castro E, Langendijk-Genevaux PS, Bulliard V, et al. (2010) PROSITE, a protein domain database for functional characterization and annotation. Nucleic Acids Res 38: D161-D166.
52. Finn RD, Mistry J, Tate J, Coggill PC, Heger A, et al. (2010) The Pfam protein families database. Nucleic Acids Res 38: D211-D222.
53. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154-D158.
54. Hsu SD, Chu CH, Tsou AP, Chen SJ, Chen HC, et al. (2008) miRNAMap 2.0: genomic maps of microRNAs in metazoan genomes. Nucleic Acids Res 36: D165-D169.
55. Sethupathy P, Corda B, Hatzigeorgiou AG (2006) TarBase: a comprehensive database of experimentally supported animal microRNA targets. RNA 12: 192-197.
56. Betel D, Wilson M, Gabow A, Marks DS, Sander C (2008) The microRNA.org resource: targets and expression. Nucleic Acids Res 36: D149-D153.
57. Friedman RC, Farh K, Burge CB, Bartel DP (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105.
58. Kondor RI, Lafferty J (2002) Diffusion kernels on graphs and other discrete structures. Proc Int Conf Mach Learn. pp 315-322.
59. Schölkopf B, Tsuda K, Vert JP (2004) Kernel Methods in Computational Biology. Cambridge, MA: MIT Press. 400 p.
60. Vapnik V (1998) Statistical Learning Theory. New York: Wiley. 338 p.
61. Pochet N, De Smet F, Suykens JAK, De Moor B (2004) Systematic benchmarking of microarray data classification: assessing the role of nonlinearity and dimensionality reduction. Bioinformatics 20: 3185-3195.
62. Duin RPW, Tax DMJ (2000) Experiments with classifier combining rules. In: Kittler J, Roli F, eds. Multiple Classifier Systems. Heidelberg: Springer-Verlag. pp 16-29.
63. Duin RPW (2002) The combining classifier: to train or not to train? Proc 16th Int Conf on Pattern Recognition 2: 765-770.
64. Kittler J (1998) Combining classifiers: a theoretical framework. Pattern Anal Appl 1: 18-27.
65. Rish I (2001) An empirical study of the naïve Bayes classifier. Proc Int Joint Conf on Artificial Intelligence. pp 41-46.
66. Hansen PC (1992) Numerical tools for analysis and solution of Fredholm integral equations of the first kind. Inverse Problems 8: 849-872.
67. Sima C, Dougherty ER (2008) The peaking phenomenon in the presence of feature selection. Pattern Recognit Lett 29: 1667-1674.
68. Raudys S, Duin R (1998) Expected classification error of the Fisher linear classifier with pseudo-inverse covariance matrix. Pattern Recognit Lett 19: 385-392.
69. Friedman JH (1989) Regularized discriminant analysis. J Am Stat Ass 84: 165-175.
70. Demšar J (2006) Statistical comparisons of classifiers over multiple data sets. J Mach Learn Res 7: 1-30.
71. Futschik ME, Sullivan M, Reeve A, Kasabov N (2003) Prediction of clinical behaviour and treatment for cancers. Appl Bioinf 2: S53-S58.
72. Mirzoeva OK, Das D, Heiser LM, Bhattacharya S, Siwak D, et al. (2009) Basal subtype and MAPK/ERK Kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibition. Cancer Res 69: 565-572.
73. Hess KR, Anderson K, Symmans WF, Valero V, Ibrahim N, et al. (2006) Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. J Clin Oncol 24: 4236-4244.
74. Ivshina AV, George J, Senko O, Mow B, Putti TC, et al. (2006) Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res 66: 10292-10301.
75. Miller LD, Smeds J, George J, Vega VB, Vergara L, et al. (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci USA 102: 13550-13555.
76. Pittman J, Huang E, Dressman H, Horng CF, Cheng SH, et al. (2004) Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes. Proc Natl Acad Sci U S A 101: 8431-8436.
77. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, et al. (2006) Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 98: 262-272.